Cargando…

Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs

Identifying effective antivirals for treating Ebola virus disease (EVD) and minimizing transmission of such disease is critical. A variety of cell-based assays have been developed for evaluating compounds for activity against Ebola virus. However, very few reports discuss the variable assay conditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postnikova, Elena, Cong, Yu, DeWald, Lisa Evans, Dyall, Julie, Yu, Shuiqing, Hart, Brit J., Zhou, Huanying, Gross, Robin, Logue, James, Cai, Yingyun, Deiuliis, Nicole, Michelotti, Julia, Honko, Anna N., Bennett, Richard S., Holbrook, Michael R., Olinger, Gene G., Hensley, Lisa E., Jahrling, Peter B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864066/ https://www.ncbi.nlm.nih.gov/pubmed/29566079 http://dx.doi.org/10.1371/journal.pone.0194880

Ejemplares similares

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells
por: Cong, Yu, et al.
Publicado: (2018)

Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015)

Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
por: Cong, Yu, et al.
Publicado: (2016)

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies
por: Dyall, Julie, et al.
Publicado: (2017)

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
por: Finch, Courtney L., et al.
Publicado: (2021)

Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
por: Covés-Datson, Evelyn M., et al.
Publicado: (2019)

In Vivo Activity of Amodiaquine against Ebola Virus Infection
por: DeWald, Lisa Evans, et al.
Publicado: (2019)

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
por: Nelson, Elizabeth A., et al.
Publicado: (2017)

A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model
por: Walpita, Pramila, et al.
Publicado: (2017)

Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018)

Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice
por: Logue, James, et al.
Publicado: (2019)

High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona
por: Honko, Anna N., et al.
Publicado: (2017)

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples
por: Postnikova, Elena N., et al.
Publicado: (2019)

Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol
por: Lara, Abigail, et al.
Publicado: (2019)

Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus
por: Kumar, Mia, et al.
Publicado: (2015)

CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection
por: Caì, Yíngyún, et al.
Publicado: (2014)

Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
por: Friedrich, Brian M., et al.
Publicado: (2012)

Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1
por: Wang, May Kwang-Mei, et al.
Publicado: (2018)

Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
por: Speranza, Emily, et al.
Publicado: (2020)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
por: Bennett, Ryan P., et al.
Publicado: (2020)

Genome Sequence of Bivens Arm Virus, a Tibrovirus Belonging to the Species Tibrogargan virus (Mononegavirales: Rhabdoviridae)
por: Lauck, Michael, et al.
Publicado: (2015)

Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
por: Bennett, Richard S., et al.
Publicado: (2021)

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
por: Bennett, Richard S., et al.
Publicado: (2021)

Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease
por: Lane, Thomas R., et al.
Publicado: (2020)

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties
por: Bennett, Ryan P., et al.
Publicado: (2022)

First Movers in Molecular Detection: Case Comparison on Harnessing Research and Development, Industry, and Entrepreneurship
por: Yeh, Kenneth B., et al.
Publicado: (2021)

Influence of in Vitro Assay Setup on the Apparent Cytotoxic Potency of Benzalkonium Chlorides
por: Groothuis, Floris A., et al.
Publicado: (2019)

Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate
por: Luke, Thomas, et al.
Publicado: (2018)

Perspective on the Relationship between GABA(A) Receptor Activity and the Apparent Potency of an Inhibitor
por: Germann, Allison L., et al.
Publicado: (2022)

Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay
por: Logue, James, et al.
Publicado: (2018)

Specific Detection of Two Divergent Simian Arteriviruses Using RNAscope In Situ Hybridization
por: Yú, Shuǐqìng, et al.
Publicado: (2016)

Development and Characterization of a cDNA-Launch Recombinant Simian Hemorrhagic Fever Virus Expressing Enhanced Green Fluorescent Protein: ORF 2b’ Is Not Required for In Vitro Virus Replication
por: Cai, Yingyun, et al.
Publicado: (2021)

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease
por: Johnson, Reed F., et al.
Publicado: (2015)

Aerosol Exposure to Rift Valley Fever Virus Causes Earlier and More Severe Neuropathology in the Murine Model, which Has Important Implications for Therapeutic Development
por: Reed, Christopher, et al.
Publicado: (2013)

Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection
por: Caballero, Ignacio S, et al.
Publicado: (2014)

The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
por: Zaucha, Gary M, et al.
Publicado: (2001)

Systems kinomics for characterizing host responses to high‐consequence pathogens at the NIH/NIAID Integrated Research Facility‐Frederick
por: Kindrachuk, Jason, et al.
Publicado: (2014)

The Convergence of High-Consequence Livestock and Human Pathogen Research and Development: A Paradox of Zoonotic Disease
por: Michelotti, Julia M., et al.
Publicado: (2018)

A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region
por: Cai, Yingyun, et al.
Publicado: (2020)

Iminosugars: A host-targeted approach to combat Flaviviridae infections
por: Evans DeWald, Lisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jv9568peetsg9a1hi0poq8f59i